Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Switzerland Praised for Early, Strong and Sustained Approach to Contain COVID-19 29/06/2021 Madeleine Hoecklin After a rocky second wave with COVID-19, Switzerland has turned a corner and is witnessing a decline in cases and deaths and the easing of restrictions, opening the country for tourism and large events. Switzerland has been praised for its response early in COVID-19 and for its economic policy throughout the pandemic. “Switzerland has navigated […] Continue reading -> Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Switzerland Praised for Early, Strong and Sustained Approach to Contain COVID-19 29/06/2021 Madeleine Hoecklin After a rocky second wave with COVID-19, Switzerland has turned a corner and is witnessing a decline in cases and deaths and the easing of restrictions, opening the country for tourism and large events. Switzerland has been praised for its response early in COVID-19 and for its economic policy throughout the pandemic. “Switzerland has navigated […] Continue reading -> Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Switzerland Praised for Early, Strong and Sustained Approach to Contain COVID-19 29/06/2021 Madeleine Hoecklin After a rocky second wave with COVID-19, Switzerland has turned a corner and is witnessing a decline in cases and deaths and the easing of restrictions, opening the country for tourism and large events. Switzerland has been praised for its response early in COVID-19 and for its economic policy throughout the pandemic. “Switzerland has navigated […] Continue reading -> Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Switzerland Praised for Early, Strong and Sustained Approach to Contain COVID-19 29/06/2021 Madeleine Hoecklin After a rocky second wave with COVID-19, Switzerland has turned a corner and is witnessing a decline in cases and deaths and the easing of restrictions, opening the country for tourism and large events. Switzerland has been praised for its response early in COVID-19 and for its economic policy throughout the pandemic. “Switzerland has navigated […] Continue reading -> Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Pandemic in a Dangerous and Fragile Phase, as Surges are Reported Globally 06/07/2021 Madeleine Hoecklin As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals. Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts. At the same time, the third […] Continue reading -> Switzerland Praised for Early, Strong and Sustained Approach to Contain COVID-19 29/06/2021 Madeleine Hoecklin After a rocky second wave with COVID-19, Switzerland has turned a corner and is witnessing a decline in cases and deaths and the easing of restrictions, opening the country for tourism and large events. Switzerland has been praised for its response early in COVID-19 and for its economic policy throughout the pandemic. “Switzerland has navigated […] Continue reading -> Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Praised for Early, Strong and Sustained Approach to Contain COVID-19 29/06/2021 Madeleine Hoecklin After a rocky second wave with COVID-19, Switzerland has turned a corner and is witnessing a decline in cases and deaths and the easing of restrictions, opening the country for tourism and large events. Switzerland has been praised for its response early in COVID-19 and for its economic policy throughout the pandemic. “Switzerland has navigated […] Continue reading -> Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Artificial Intelligence ‘Very Promising’ for Health, Says WHO 28/06/2021 Madeleine Hoecklin Artificial intelligence (AI) has the potential to strengthen the delivery of healthcare and move the world closer towards universal health coverage, but ethical considerations and human rights must be central to the design, development, and deployment of AI technologies, according to a new report released on Monday. The World Health Organization’s (WHO) Ethics and Governance […] Continue reading -> Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Antibody Cocktail Reduces Risk of Death by 20% in Patients lacking Adequate SARS-CoV2 Immune Response 17/06/2021 Madeleine Hoecklin A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial. Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading -> Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Latin America Plagued by Slow Vaccine Rollouts, While Region Remains Major COVID Epicenter 17/06/2021 Madeleine Hoecklin & Raisa Santos Despite the global decline in COVID-19 cases by 12% over the last week, countries in Central and South America continue to be epicenters of pandemic, with high mortality rates and insufficient access to vaccines. Over 1.1 million new COVID-19 cases and 31,000 deaths were reported in the Americas over the last week, officials from the […] Continue reading -> Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Groundbreaking Study: Mosquitoes Armed with Wolbachia Bacteria Reduced Symptomatic Dengue Infections by 77% In Indonesian Trial 16/06/2021 Madeleine Hoecklin In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released. The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading -> Posts navigation Older postsNewer posts